Publications
4666 Results
- Journal / Conference
- Cancer Apr 15;125(8):1313-1318; Dec 18. doi: 10.1002/cncr.31925. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID30561776
- PMC
- PMC6443419
Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups
- Journal / Conference
- Journal of Thoracic Oncology Feb;14(2):298-303
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID30292852
- PMC
- PMC6348032
- Study Number(s)
- S0023
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer
- Journal / Conference
- JAMA Oncology Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID30653226
- PMC
- PMC6459217
- Study Number(s)
- S1204
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
- Journal / Conference
- Leukemia Research Mar;78:29-33
- Year
- 2019
- Research Committee(s)
- Leukemia
- PMID
- PMID30673620
- PMC
- PMC6615032
- Study Number(s)
- S0106
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ ECOG-ACRIN Study (S0106 and E1900)
- Journal / Conference
- European Urology Apr;75(4):612-614
- Year
- 2019
- Research Committee(s)
- Genitourinary
- PMID
- PMID30616946
- Study Number(s)
- S1011
What is the standard of care for pelvic lymphadenectomy performed at the time of radical cystectomy? [Editorial]
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl 4; abstr 414); ASCO GI Cancers Symposium (Jan 17-19, 2019, San Francisco, CA), poster
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl 4; abstr TPS728); ASCO GI Cancers Symposium (Jan. 17-19, 2019, San Francisco, CA), submitted 9/25/18
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
COlorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC)
- Journal / Conference
- Journal of the National Cancer Institute Feb 1;111(2):170-179
- Year
- 2019
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID30726946
- PMC
- PMC6376913
- Study Number(s)
- C89803
Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)
- Journal / Conference
- Leukemia and Lymphoma Jan 10:1-8. doi: 10.1080/10428194.2018.1563691. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lymphoma
- PMID
- PMID30628511
- PMC
- PMC6620162
- Study Number(s)
- S9704
Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis
- Journal / Conference
- New England Journal of Medicine Jan 24;380(4):393-394
- Year
- 2019
- Research Committee(s)
- Cancer Control
- PMID
- PMID30673548
- PMC
- n/a - correspondence/letter to editor
- Study Number(s)
- SWOG-9217